InTrack Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,831
| Closed | -$370K | – | 133 |
|
|
2024
Q1 | $370K | Buy |
6,831
+166
| +2% | +$9K | 0.27% | 103 |
|
|
2023
Q4 | $342K | Sell |
6,665
-9,720
| -59% | -$499K | 0.26% | 106 |
|
|
2023
Q3 | $951K | Buy |
16,385
+2,924
| +22% | +$170K | 0.84% | 33 |
|
|
2023
Q2 | $861K | Sell |
13,461
-1,166
| -8% | -$74.6K | 0.7% | 49 |
|
|
2023
Q1 | $1.01M | Buy |
14,627
+1,660
| +13% | +$114K | 0.92% | 32 |
|
|
2022
Q4 | $933K | Sell |
12,967
-5,187
| -29% | -$373K | 0.93% | 35 |
|
|
2022
Q3 | $1.29M | Buy |
18,154
+5,339
| +42% | +$380K | 1.43% | 19 |
|
|
2022
Q2 | $987K | Sell |
12,815
-3,002
| -19% | -$231K | 1.01% | 33 |
|
|
2022
Q1 | $1.16M | Sell |
15,817
-962
| -6% | -$70.2K | 0.94% | 36 |
|
|
2021
Q4 | $1.05M | Buy |
16,779
+2,240
| +15% | +$140K | 0.72% | 52 |
|
|
2021
Q3 | $853K | Buy |
14,539
+10,319
| +245% | +$605K | 0.62% | 62 |
|
|
2021
Q2 | $281K | Sell |
4,220
-280
| -6% | -$18.6K | 0.22% | 99 |
|
|
2021
Q1 | $284K | Buy |
+4,500
| New | +$284K | 0.26% | 87 |
|